drugset / Trial / NCT03654144

Role of Dienogest in the Treatment of Patient With Symptomatic Adenomyosis

NCT03654144

Phase 4 Unknown 100 enrolled Assiut University
RandomizedParallel-groupOpen-labelTreatment

Summary

Adenomyosis was first described as endometrial glands in the myometrium of the uterus. The current definition of adenomyosis is provided in 1972 'the benign invasion of endometrium into the myometrium, producing a diffusely enlarged uterus which microscopically exhibits ectopic non-neoplastic, endometrial glands and stroma surrounded by the hypertrophic and hyperplastic myometrium

Timeline

Start
2018-11
Primary completion
2019-12
Completion
2020-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Dienogest Small molecule Oral

Indications